Delivery Order SPE2DB22D1103-SPE2DB24FTKQ9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,808.43, is for the delivery of Trileptal 300 mg/5 ml suspension, a pharmaceutical product, with a completion date of January 31, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of Trileptal 300 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $10,177.84 and an ultimate completion date of September 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is a major pharmaceutical distribution company serving the U.S. federal government, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- The Defense Logistics Agency awarded a $20,903.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trileptal (oxcarbazepine) 300 mg tablets in quantities of 100 units. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order represents a...
- This federal contract award, valued at $16,958.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567829232 TRILEPTAL 300 MG TABLET 100S, with an ultimate completion date of April 8, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there is no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,067.99 firm fixed-price contract is for the supply of Trileptal 300 mg/5 ml suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,052.32 contract is for the procurement of 4,562,235,883 units of the medication Trileptal 300 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a $1,890.63 order for the pharmaceutical product Trileptal 300 mg/5 ml suspension. The contract has a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,869.87 firm fixed price Delivery Order is for the supply of 4558630619 - TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The contract has a completion date of September 29, 2022 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,176.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and is priced on a firm fixed-price basis. The contract provides for the delivery of Trileptal, a 300 mg/5 ml suspension medication used to treat epilepsy, with a completion date of May 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTKQ9Delivery Order
This federal contract award, valued at $7,004.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Trileptal 300 mg tablets, a medication used to treat seizure disorders. The contract is a Firm Fixed Price Delivery Order with a completion date of May 14, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and the company is a subsidiary of Amerisourcebergen Corporation. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 5/13/24 |